Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2024-10-15 00:00:00 ET · period of report 2024-10-12 · accession 0001415889-24-025148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-15 | 2024-10-12 | ACAD | Ndu Adora | Dir | M - OptEx | — | +4,381 | 15.4K | +40% | — |
| D | 2024-10-15 | 2024-10-12 | ACAD | Ndu Adora | Dir | M - OptEx | $0.00 | -4,381 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-12 | M | A | 4,381 | — | 15,414 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. |
| 2 | Derivative | Restricted Stock Units | 2024-10-12 | M | D | 4,381 | $0.00 | 0 | D | — · — to — | 4,381 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. (F2) The restricted stock units vested in two equal annual installments on each of October 12, 2023 and October 12, 2024. |